The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia

Y. Ichikawa, M. Yasui, H. Murakami, M. Fujimura (Kanazawa, Japan)

Source: Annual Congress 2006 - Interstial lung diseases
Session: Interstial lung diseases
Session type: Poster Discussion
Number: 4759
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Ichikawa, M. Yasui, H. Murakami, M. Fujimura (Kanazawa, Japan). The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia. Eur Respir J 2006; 28: Suppl. 50, 4759

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated levels of serum SP-A in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020


KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 23: 142-145
Year: 2004



Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019



KL-6/MUC1 in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005

Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Annual changes of serum KL-6 were inversely correlated with those of respiratory function parameters in patients with nonspecific interstitial pneumonia
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Alterations of surfactant phospholipids in lungs with chronic recurrent respiratory chlamydial infection
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Time-course of upper respiratory tract viral infection and COPD exacerbation
Source: Eur Respir J, 54 (4) 1900407; 10.1183/13993003.00407-2019
Year: 2019



Serum chitotriosidase levels in granulomatous lung disorders
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002

Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia
Source: Eur Respir J 2006; 27: 253-260
Year: 2006



Serum KL-6 level is increased in patients with pneumocystis pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 101s
Year: 2006

Viral upper respiratory infection and acute asthma exacerbation
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009